Premium Information is available for this item - Upgrade for $1 a day
6505-01-703-0084
Coronavirus Vaccine
6505017030084 017030084 1637153 6505NCM228544 NDC80777-0100-99
To be administered to humans to provide acquired immunity against corona virus disease; to include severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2 ), severe acute respiratory syndrome corona virus (SARS-CoV) and Middle East respiratory syndrome corona virus (MERS-CoV). View more Coronavirus Vaccine
November 2023
2
Marketplace 6505-01-703-0084
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-703-0084 5+ Documents (More...)
Restrictions 6505-01-703-0084
6505-01-703-0084 is a Coronavirus Vaccine that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Approved Sources 6505-01-703-0084
- Part Number
- Manufacturer
- Status
- NDC80777-0100-99
- Manufacturer
- 8PTM0 - Moderna Us, Inc. (Active)
- Primary Buy
- Primary Buy
- 1637153
- 89875 - Defense Logistics Agency (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- 6505NCM228544
- 64616 - Defense Medical Standardization (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
DLA Procurement Analysis 6505-01-703-0084
- Last Stock Position:
- 90 In Stock
- DLA Administrative Lead Time:
- Subscribe
- DLA Production Lead Time:
- Subscribe